Indofarma Tbk PT
IDX:INAF

Watchlist Manager
Indofarma Tbk PT Logo
Indofarma Tbk PT
IDX:INAF
Watchlist
Price: 126 IDR Market Closed
Market Cap: Rp390.5B

Operating Margin

-112.1%
Current
Improving
by 7.1%
vs 3-y average of -119.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-112.1%
=
Operating Income
Rp-231.2B
/
Revenue
Rp206.2B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-112.1%
=
Operating Income
Rp-231.2B
/
Revenue
Rp206.2B

Peer Comparison

Country Company Market Cap Operating
Margin
ID
Indofarma Tbk PT
IDX:INAF
390.5B IDR
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
530.8B USD
Loading...
CH
Roche Holding AG
SIX:ROG
279.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
214.1B GBP
Loading...
CH
Novartis AG
SIX:NOVN
224.2B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
267.6B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.1B USD
Loading...
FR
Sanofi SA
PAR:SAN
96.7B EUR
Loading...

Market Distribution

Lower than 95% of companies in Indonesia
Percentile
5th
Based on 1 283 companies
5th percentile
-112.1%
Low
-111 644.7% — 0%
Typical Range
0% — 12.9%
High
12.9% — 524 864.9%
Distribution Statistics
Indonesia
Min -111 644.7%
30th Percentile 0%
Median 6.1%
70th Percentile 12.9%
Max 524 864.9%

Indofarma Tbk PT
Glance View

Market Cap
390.5B IDR
Industry
Pharmaceuticals

PT Indofarma Tbk is engaged in the pharmaceutical and healthcare businesses. The company is headquartered in Bekasi, Jawa Barat and currently employs 1,095 full-time employees. The company went IPO on 2001-04-17. The firm's business segment based on the products consists of the drug business segment and other medical equipment segment. The medical equipment segment consists of diagnostic and medical equipment. Its business segment based on geographical distribution area covers five regions consisting of Sumatra, Java, Kalimantan, Sulawesi and Bali, West Nusa Tenggara, and East Indonesia. Its products and services include generic drugs, over-the-counter and food, medical devices, non-medical devices and household health products. The firm carries out business activities to produce either alone or under cooperation for finished drug products, such as essential medicines, generic medicines with logos, generic medicines with trade names, traditional medicines, medical equipment, diagnostics, as well as food products, both related to health maintenance and improvement as well as health restoration.

INAF Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-112.1%
=
Operating Income
Rp-231.2B
/
Revenue
Rp206.2B
What is Indofarma Tbk PT's current Operating Margin?

The current Operating Margin for Indofarma Tbk PT is -112.1%, which is above its 3-year median of -119.1%.

How has Operating Margin changed over time?

Over the last 3 years, Indofarma Tbk PT’s Operating Margin has decreased from -6.5% to -112.1%. During this period, it reached a low of -261.1% on Sep 30, 2024 and a high of -6.5% on Sep 30, 2022.

Back to Top